: Friday, July 10, 2020
Korea‘s Bio Industry
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
‘Too early to call Sweden’s Covid-19 response fail...
Sweden has been under fire for failing to contain Covid-19 by seeking herd immunity. However, some experts here say it is still too early to call Sweden’s strategy a failure.The Nordic country had 73,858 confirmed cases ...
Seoul becomes No. 2 hot spot of Covid-19 outbreak
Korea's new virus cases fell below 50 on Thursday, but health officials maintained alertness amid the high risk of community spread and little signs of a slowdown in both local and imported infections.According to th...
Korea to spend ₩193.6 billion on Covid-19 treatmen...
The government said it would invest 193.6 billion won ($161.1 million) in developing a treatment and a vaccine against the new coronavirus.The government held a meeting to discuss executing the extra budget to develop a ...
WUH’s affiliate firm exports mobile CT for Covid-19 to Iran
NanoFocusRay, an industry-academic cooperation com...
1 vs. 3,055: Koreans’ rate of Covid-19 antibodies
The health authorities’ recent antibody testing on...
Court rejects Medytox's request not to revoke license of Medytoxin
A local court on Wednesday has turned down Medytox...
Ministry OKs Dongkook's P3 trial into benign prostatic hyperplasia treatment
Dongkook Pharmaceutical said that the Ministry of Food and Drug Safety...
KIST finds agent causing high blood pressure at heart
A research team of Korea Institute of Science and Technology (KIST) sa...
'Xolair’s reimbursement will change treatment paradigm for asthma patients'
Novartis Korea will be able to strengthen its position in the severe a...
Biotech firms offer bonus shares to increase liquidity
Four listed biotech companies have announced a bonus issue in the past...
‘Electrical stimulation reduces pain, recovery period after surgery’
A Severance Hospital research team has found that applying intra-muscu...
Drugmakers appeal limited insurance benefit for dementia drug choline alfoscerate
Sixty-six manufacturers of choline alfoscerate, a dementia drug, filed...
IUH cured Covid-19 patients with plasma of different blood types
Will Biogen win FDA nod for Alzheimer’s drug aducanumab?
‘Raising HDL cholesterol level prevents benign prostatic hyperplasia’
Provincial new virus cases surpass Seoul metro region
Ministry set to better manage generic drugs made by consignment
60% of Korean diabetics have difficulty taking glycated hemoglobin tests
‘Hypertension drug Opsumit enhances right ventricle function’
Crystal Genomics confirms safety of super-bacteria antibiotic candidate
Psychiatric patients left in blind spot amid Covid-19
Method developed to predict early death risks before heart valve surgery
[News Focus] Who will win BTX strain dispute – Daewoong or Medytox?
‘Study results on MSD’s Keytruda very disappointing’
Regulator OKs Janssen's multiple myeloma treatment
Daewoong to conduct P1 trial of Covid-19 treatment in Indonesia
‘Covid-19 antibody tests need at least 10,000 people’
ITC ruling gives Medytox upper hand in BTX strain dispute
Joint efforts of 3 institutions discover prognostic biomarker for brain cancer
Experts showed mixed preferences between 2 diabetes treatments
Gambia asks Korea to help set up national health insurance system
Korea added 1,222 HIV/AIDS patients in 2019
[Reporter's Notebook] Drugmakers introduce creative PR formats amid Covid-19
[Reporter's Notebook] Korean firms found something missing in ‘virtual’ ASCO 2020
[Column] 'New normal' of healthcare in post-corona era
[Special] HIV patients pushed aside amid Covid-19 crisis
Covid-19 increases smartphone use, reduces drinking
‘Choose home-cooked meals over fast food amid Covid-19’
[Analysis] Revocation of Medytox license tolls death knell for once-promising biotech firm
[ASCO 2020 ⑥] Alteogen confirms safety, efficacy of HER2 breast cancer therapy
[ASCO 2020 ⑤] Lunit opens possibility of personalized cancer treatment with AI platform
Adolescent Protection Policy
E-mail address privacy
The Korean Doctors’ Weekly Co., Ltd.
76-1, Dongmak-ro, Mapo-gu, Seoul, Korea
Email : firstname.lastname@example.org
Title : Korea Biomedical Review
Online newspaper registration number : Seoul 아 04285
Date of registration : December 19, 2016
Publishing date : February 22, 2017
Publisher-Editor : Yang Kyung-cheol
Chief Executive Officer : Yang Kyung-cheol
Executive Editor : Choi Sung-jin
pyright © 2020 KBR. All rights reserved.
Back to Top